NASDAQ OMX

ARKAY Non Alcoholic Cinnamon Whisky Has Officially Entered the U.S. Market

20.2.2015 07:04 | NASDAQ OMX

Del

FORT LAUDERDALE, Fla., 2015-02-20 07:04 CET (GLOBE NEWSWIRE) -- ARKAY NON ALCOHOLIC CINNAMON WHISKY has officially entered the U.S. market. This alcohol-free whisky will join the ArKay family, which entered the U.S. market in 2011.

ARKAY Cinnamon whisky is a version of a combination of non-alcoholic American bourbon, Spanish sherry and Spanish Malaga aromas. It is the rare taste of a bonder's style Pot Still American Whisky and is known for its sophisticated and complex taste profile, possessing Cinnamon with spices. Hints of fresh coffee are also found in each taste of ARKAY Cinnamon Whisky.

"ARKAY Cinnamon non-alcoholic Whisky is characterized by full complex flavors," said Jose Jaramillo, VP North American beverages Division at ARKAY. "We are thrilled to bring ARKAY Cinnamon non-alcoholic Whisky to American whisky lovers as ARKAY has become highly desired."

Each batch of ARKAY Cinnamon is made from a mash of malted and un-malted barley aromas. ARKAY Cinnamon Whisky is distributed by ARKAY Beverages Inc.

ARKAY Cinnamon Whisky will be released in the U.S., beginning this month and sold at a suggested retail price of $49.99 for a 33.3 FL Oz. Pre-orders are accepted on line at www.arkaybeverages.com.

ARKAY Cinnamon joins ARKAY Beverages' portfolio of Whiskies including ARKAY honey and ARKAY Vanilla to be launched spring 2015.

Please taste ARKAY responsibly.

About ARKAY Beverages Inc.

ARKAY Beverages Inc. is the world's first alcohol-free liquor company and the largest subsidiary of Mougins, France-based ARKAY Distribution www.arkay.fr which remains a private company.

The company's leading non-alcoholic spirits include such prestigious brands as ARKAY Non-alcoholic Whisky, vodka, brandy, tequila, rum, gin, limoncello, margarita, orange napoleon, Irish cream, coffee liquor, peppermint, 84 new alcohol-free flavors are to be launched this year as well as a collection of non-alcoholic beer and cocktails sold in glass bottles, aluminum cans and kegs.

ARKAY Beverages Inc. is based in Fort Lauderdale, Florida.

ARKAY reminds to everyone, "Don't drink and drive unless it's ARKAY®."

For more information contact:

Please visit www.arkayglobal.com, www.arkaydepot.com and www.arkaymaltbeverages.com

         ARKAY Beverages Inc.
         Media Relations
         +1-855-416-2565
         www.arkaybeverages.com

Om NASDAQ OMX

NASDAQ OMX
NASDAQ OMX
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com
NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

Aryaka Announces Partnership with GAB to Further Expand Market Presence in Germany22.3.2017 19:00

MILPITAS, Calif., 2017-03-22 19:00 CET (GLOBE NEWSWIRE) -- Aryaka®, the leading global SD-WAN provider, announced a strategic partnership with GAB Enterprise IT Solutions GmbH, a global system integrator for the latest Microsoft technologies. With multiple locations in Germany, GAB Enterprise IT Solutions GmbH specializes in implementing, transforming, and operating private, hybrid and public cloud infrastructures. By integrating Aryaka’s global SD-WAN technology, GAB can provide its global enterprise customers with a next-generation MPLS replacement solution. "Aryaka’s global SD-WAN enables our global customers to connect their worldwide subsidiaries in a way that is distinctly more cost-efficient than traditional, existing solutions, and it allows us to offer connectivity to cloud services directly, along with built-in WAN Optimization," Florian Klante, Principal Consultant at GAB summarized. “Our new partnership with GAB enhances our channel presence in Germany,” s

Call for Entries Issued for Fourteenth International Business Awards22.3.2017 13:00

FAIRFAX, Va., 2017-03-22 13:00 CET (GLOBE NEWSWIRE) -- The Stevie® Awards have issued the call for entries for The 14th Annual International Business Awards, the world's premier business awards competition, which attracts nominations from organizations in more than 60 nations and territories each year. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/8540ffb4-6337-429d-9f7c-3574f68f49c3 All individuals and organizations worldwide -- public and private, for-profit and non-profit, large and small -- may submit nominations to The International Business Awards. The early-bird entry deadline, with reduced entry fees, is 12 April. The final entry deadline is 10 May, and late entries will be accepted through 14 June with payment of a late fee. Entry details are available at www.StevieAwards.com/IBA. An international judging panel of more than 150 executives will determine the Stevie Award winners. Results will be announced 10 Au

Lumenis Unveils its new Moses™ Technology at European Association of Urology Annual Congress22.3.2017 11:22

YOKNEAM, Israel, 2017-03-22 11:22 CET (GLOBE NEWSWIRE) -- Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announces the upcoming launch of its new Moses™ holmium technology in a range of launch events at the 32nd annual European Association of Urology (EAU) Congress, taking place in London from March 24-27, 2017. Moses™ is a new breakthrough patent pending technology that redefines holmium lithotripsy technology as it exists today. The unique Moses technology is designed to significantly reduce retropulsion during lithotripsy, enabling less stone migration and a more efficient procedure. Moses™ technology includes a proprietary combination of holmium lasers and fibers that optimize holmium energy transmission allowing the surgeon more control regardless of the working distance between the fiber and the stone. The Moses™ tailored premium fiber range of 200, 365, and 550 D/F/L is designed for optimal energy tr

Minerva Neurosciences Announces Recent Exercise of Warrants by Institutional Stockholders and Open Market Purchase of Common Stock by Chairman of Its Board of Directors21.3.2017 21:10

WALTHAM, Mass., 2017-03-21 21:10 CET (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat unmet medical needs of central nervous system (CNS) disorders, today announced the recent exercise of warrants held by certain institutional stockholders in connection with a private placement that took place in March 2015, as well as a purchase of common stock completed on the open market by the chairman of Minerva’s board of directors. Since December 31, 2016, warrants with respect to a total of 1,621,073 shares have been exercised by such stockholders at an exercise price of $5.772 per share.  As a result, the Company has received approximately $9.4 million in proceeds since December 31, 2016. The warrants issued in connection with the private placement expired on March 20, 2017.  Separately, 50,000 shares of Minerva common stock have been purchased by Marc Beer, chairman of th

RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III Study with RHB-104 for Crohn's Disease21.3.2017 14:00

A first randomized, double-blind, placebo-controlled Phase III clinical study with RHB-104 for the treatment of Crohn’s disease (the MAP US study) is ongoing in the U.S. and additional countries   The open-label extension study (the MAP US2 study) is intended to assess the safety and efficacy of RHB-104 in patients who have completed 26 weeks of treatment in the ongoing MAP US Phase III study and remain with active Crohn’s disease (CDAI>150); these patients have the opportunity to receive treatment with RHB-104 for a 52-week period in the open-label extension study   The MAP US2 open-label extension study is considered separate from the ongoing MAP US Phase III study and data collected will be supplemental to the MAP US study data   A second independent DSMB meeting for the MAP US Phase III study is expected in mid-2017, including an interim efficacy analysis and an evaluation of an option for early stop for success for overwhelming efficacy   RHB-104 is a pr

Nexeo Solutions Launches Two B2B Storefronts with CloudCraze, Avionos21.3.2017 14:00

CHICAGO, 2017-03-21 14:00 CET (GLOBE NEWSWIRE) -- Global leader in chemical and plastics distribution, Nexeo Solutions, has launched two new storefronts for their retail and business customers in North America. Nexeo Solutions used CloudCraze, a native commerce technology on Salesforce, to power the new commerce experience and customer portal. Digital services provider Avionos led the implementation, user experience and site design for Nexeo 3D and MyNexeo. MyNexeo provides a one-stop shop for Nexeo Solutions’ customers to get rich product data, place orders, retrieve material documentation, track their deliveries and manage invoices all within one digital experience. It provides a platform where customers can get fast and convenient self-service 24/7 to operate their business day or night. The second site, Nexeo 3D is a robust digital storefront that allows retail businesses to browse and purchase the company’s full line of premium 3D printing filaments for fused filament fabric

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom